A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study will check how well a new medicine, GSK5764227, works, how safe it is and how the body handles it in participants all around the world with advanced inoperable or metastatic gastrointestinal cancer who have previously received treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony rozpoznanie nieopeacyjnego lub przerzutowego raka jelita grubego lub odbytnicy
- •Wcześniejsze leczenie systemowe (1-2 serie) z dokumentowanym pogorszeniem
- •Dostarcz próbkę tkanki nowotworu
- •Przynajmniej jeden mierzalny guz
- •Gotowość do stosowania antykoncepcji
- •Zdolność do wyrażenia świadomej zgody
- •Zadowalająca funkcja organów wewnętrznych
✗ Disqualifies
- •Inny nowotwór aktywny lub wymagający leczenia w ostatnich 24 miesiącach (z wyjątkiem zmian skórnych)
- •Poważna operacja w ciągu ostatnich 28 dni
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (85)
GSK Investigational Site
Los Alamitos, United States
GSK Investigational Site
Los Angeles, United States
GSK Investigational Site
Santa Monica, United States
GSK Investigational Site
Whittier, United States
GSK Investigational Site
Aurora, United States
GSK Investigational Site
New York, United States
GSK Investigational Site
New York, United States
GSK Investigational Site
Durham, United States
GSK Investigational Site
Houston, United States
GSK Investigational Site
San Antonio, United States
GSK Investigational Site
Wenatchee, United States
GSK Investigational Site
Madison, United States
GSK Investigational Site
Heidelberg, Australia
GSK Investigational Site
Melbourne, Australia
GSK Investigational Site
Bonheiden, Belgium
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Leuven, Belgium
GSK Investigational Site
Roeselare, Belgium
GSK Investigational Site
Porto Alegre, Brazil
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
Teresina, Brazil
GSK Investigational Site
Calgary, Canada
GSK Investigational Site
Toronto, Canada
GSK Investigational Site
Montreal, Canada
GSK Investigational Site
Sherbrooke, Canada
GSK Investigational Site
Helsinki, Finland
GSK Investigational Site
Helsinki, Finland
GSK Investigational Site
Kuopio, Finland
GSK Investigational Site
Tampere, Finland
GSK Investigational Site
Dijon, France
GSK Investigational Site
Marseille, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Poitiers, France
GSK Investigational Site
Rennes, France
GSK Investigational Site
Villejuif, France
GSK Investigational Site
Bochum, Germany
GSK Investigational Site
Düsseldorf, Germany
GSK Investigational Site
Frankfurt, Germany
GSK Investigational Site
Lübeck, Germany
GSK Investigational Site
München, Germany
GSK Investigational Site
Milan, Italy
GSK Investigational Site
Milan, Italy
GSK Investigational Site
Pisa, Italy
GSK Investigational Site
Roma, Italy
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Chiba, Japan
GSK Investigational Site
Hokkaido, Japan
GSK Investigational Site
Osaka, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tuxtla Gutiérrez, Mexico
GSK Investigational Site
Cuernavaca, Mexico
GSK Investigational Site
Mexico City, Mexico
GSK Investigational Site
Mexico City, Mexico
GSK Investigational Site
San Pedro Garza García, Mexico
GSK Investigational Site
Amsterdam, Netherlands
GSK Investigational Site
Maastricht, Netherlands
GSK Investigational Site
Rotterdam, Netherlands
GSK Investigational Site
Utrecht, Netherlands
GSK Investigational Site
Lrenskog, Norway
GSK Investigational Site
Oslo, Norway
GSK Investigational Site
Stavanger, Norway
GSK Investigational Site
La Villa de Los Santos, Panama
GSK Investigational Site
Punta Pacifica Panama City Panama, Panama
GSK Investigational Site
Brzozów, Poland
GSK Investigational Site
Koszalin, Poland
GSK Investigational Site
Warsaw, Poland
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
HebrOn, Spain
GSK Investigational Site
Madrid, Spain
GSK Investigational Site
Madrid, Spain
GSK Investigational Site
Madrid, Spain
GSK Investigational Site
Pamplona, Spain
GSK Investigational Site
Santander, Spain
GSK Investigational Site
Zaragoza, Spain
GSK Investigational Site
Gothenburg, Sweden
GSK Investigational Site
Lund, Sweden
GSK Investigational Site
Stockholm, Sweden
GSK Investigational Site
Uppsala, Sweden
GSK Investigational Site
Manchester, United Kingdom
Trial contact
US GSK Clinical Trials Call Center
EU GSK Clinical Trials Call Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.